Active	Status	Sponsor type	Region	Phase	Filter
8 Active 10 Inactive 18 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lam, Wai-Ching
INSITE-DME, NCT05610319: Treat & Extend Versus Fixed Dosing with Faricimab for Management of Diabetic Macular Edema: a Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial	Active, not recruiting	4	446	Europe, Canada, US, RoW	Faricimab	McMaster University, Hoffmann-La Roche	Diabetic Macular Edema	12/26	12/26
Fraser-Bell, Samantha
INSITE-DME, NCT05610319: Treat & Extend Versus Fixed Dosing with Faricimab for Management of Diabetic Macular Edema: a Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial	Active, not recruiting	4	446	Europe, Canada, US, RoW	Faricimab	McMaster University, Hoffmann-La Roche	Diabetic Macular Edema	12/26	12/26
NCT06116916: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema	Recruiting	2	150	Japan, US, RoW	KHK4951, Aflibercept Injection	Kyowa Kirin Co., Ltd.	Diabetic Macular Edema (DME)	11/25	12/25
NCT06116890: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration	Recruiting	2	180	Japan, US, RoW	KHK4951, Aflibercept Injection	Kyowa Kirin Co., Ltd.	Neovascular Age-Related Macular Degeneration (nAMD)	11/25	12/25
Mehta, Hemal
INSITE-DME, NCT05610319: Treat & Extend Versus Fixed Dosing with Faricimab for Management of Diabetic Macular Edema: a Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial	Active, not recruiting	4	446	Europe, Canada, US, RoW	Faricimab	McMaster University, Hoffmann-La Roche	Diabetic Macular Edema	12/26	12/26
Fan, Mannie
INSITE-DME, NCT05610319: Treat & Extend Versus Fixed Dosing with Faricimab for Management of Diabetic Macular Edema: a Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial	Active, not recruiting	4	446	Europe, Canada, US, RoW	Faricimab	McMaster University, Hoffmann-La Roche	Diabetic Macular Edema	12/26	12/26
Harrison, Xanthe
INSITE-DME, NCT05610319: Treat & Extend Versus Fixed Dosing with Faricimab for Management of Diabetic Macular Edema: a Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial	Active, not recruiting	4	446	Europe, Canada, US, RoW	Faricimab	McMaster University, Hoffmann-La Roche	Diabetic Macular Edema	12/26	12/26